Freesia develops open tools and technology at the intersection of bioengineering, artificial intelligence, and medical research — accelerating discovery from sequence to insight.
Freesia operates at the convergence of biology and computation, developing technology that makes advanced research accessible.
Client-side analytical tools that decode DNA, RNA, and protein sequences to uncover their fundamental mechanisms and influence on human biology, health, and disease.
Machine learning models trained on biological data to surface patterns, predict outcomes, and accelerate the path from hypothesis to result.
Privacy-first software foundations designed for academic and clinical research laboratories, establishing the rigorous groundwork for our long-term roadmap in medical-grade platforms.
BLAST alignment powered entirely in your browser. Paste sequences or upload FASTA files — all computation runs locally on your machine.
Privacy note: This tool runs entirely in your browser using JavaScript. No sequence data is transmitted to Freesia or any server. All computation happens locally on your device. Note that browser extensions or other software on your device may independently access page content, which is outside Freesia's control.
Founded in 2026 and incorporated in Delaware, Freesia Labs is an early-stage company with an ambitious mandate: build the foundational software that the next generation of biomedical research needs.
"We believe the most important advances in medicine and biology will come from teams that deeply understand the science and are empowered by the right tools."
We're just getting started. If you're interested in what we're building, reach out.